Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial

Domenica Lorusso, Giovanni Scambia, Sandro Pignata, Roberto Sorio, Giulia Amadio, S. Lepori, A. M. Mosconi, Carmela Pisano, Giorgia Mangili, Giuseppa Maltese, Roberto Sabbatini, G. Artioli, T. Gamucci, Marilena Di Napoli, Ettore Capoluongo, Vienna Ludovini, Francesco Raspagliesi, Gabriella Ferrandina

Research output: Contribution to journal › Article › peer-review

Fingerprint Dive into the research topics of 'Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: The MITO 15 trial'. Together they form a unique fingerprint.